Oxford Instruments (OXIG) Q3 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 TU earnings summary
15 Jan, 2026Executive summary
Full-year adjusted operating profit expected to align with market expectations, with consensus for FY26 at £70.2m–£73.0m and a mean of £71.8m.
Strong order momentum in Advanced Technologies, with year-to-date orders up 44.5% OCC year-over-year.
Imaging and Analysis division order intake grew 2.4% OCC compared to Q3 last year; book-to-bill ratio at 1.1.
Group year-to-date book-to-bill ratio stands at 1.2, indicating robust demand.
Financial highlights
Adjusted operating profit for FY26 expected to face a £5.5m currency headwind versus prior year.
Cost restructuring in the Belfast-based imaging business is delivering expected H2 benefits.
Outlook and guidance
No change to full-year guidance; focus remains on executing the current orderbook.
Order book coverage for Advanced Technologies extends well into FY27.
Q4 trading update scheduled for 14 April 2026; preliminary FY26 results on 9 June 2026.
Latest events from Oxford Instruments
- Revenue up 9.8%, margin target above 20%, with strong growth and strategic transformation.OXIG
H2 202423 Feb 2026 - Strong 10.4% revenue growth and robust order book drive positive full-year outlook.OXIG
H1 202515 Jan 2026 - Order recovery and cost actions set stage for stronger H2 after a challenging first half.OXIG
H1 202616 Dec 2025 - Record revenue, margin expansion, and NanoScience divestment drive strong outlook.OXIG
H2 202514 Nov 2025 - H1 order intake rose 1% OCC, but revenues fell 8% OCC; full-year outlook remains stable.OXIG
H1 2026 TU13 Oct 2025 - Revenue up 10% at constant currency, but currency headwinds to impact reported profit.OXIG
Trading Update13 Jun 2025 - Strong revenue and margin growth driven by robust divisional performance and strategic execution.OXIG
Trading Update6 Jun 2025